IMUX IMMUNIC, INC.
Healthcare · Market cap: $102.6M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $109.6K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $146.3K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $8.8K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $18.3K | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $100.4K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $246.8K | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$630.2K20 buy days
Sold$00 sell days
Net insider flow+$630.2Knet buying · 5 years
Latest trade2025-06-13Nash Duane
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-06-13 | Buy | Nash Duane | Chair | 20,000 | $0.83 | $16.6K | 1 |
| 2025-06-05 | Buy | Neermann Joerg | Director | 30,000 | $0.76 | $22.8K | 1 |
| 2025-06-05 | Buy | Tardio Jason | President | 12,512 | $0.79 | $9.9K | 1 |
| 2025-06-04 | Buy | Neermann Joerg | Director | 70,000 | $0.77 | $53.9K | 1 |
| 2025-06-04 | Buy | Vitt Daniel | CEO | 15,000 | $0.77 | $11.6K | 1 |
| 2025-06-03 | Buy | Rudick Richard Alan | Director | 143,075 | $0.70 | $100.2K | 1 |
| 2025-06-03 | Buy | Whaley Glenn | CFO | 45,000 | $0.71 | $32.0K | 1 |
| 2024-11-12 | Buy | Rudick Richard Alan | Director | 87,300 | $1.15 | $100.4K | 1 |
| 2024-02-26 | Buy | Vitt Daniel | CEO | 14,000 | $1.31 | $18.3K | 1 |
| 2023-05-15 | Buy | Whaley Glenn | CFO | 5,000 | $1.75 | $8.8K | 1 |
| 2022-12-14 | Buy | Neermann Joerg | Director | 47,000 | $1.26 | $59.2K | 1 |
| 2022-12-13 | Buy | Neermann Joerg | Director | 35,000 | $1.25 | $43.8K | 1 |
| 2022-11-23 | Buy | Neermann Joerg | Director | 18,000 | $1.39 | $25.0K | 1 |
| 2022-11-22 | Buy | Vitt Daniel | CEO | 8,000 | $1.35 | $10.8K | 1 |
| 2022-11-07 | Buy | Whaley Glenn | CFO | 5,000 | $1.50 | $7.5K | 1 |
| 2022-06-03 | Buy | Vitt Daniel | CEO | 5,000 | $3.10 | $15.5K | 1 |
| 2022-06-03 | Buy | Whaley Glenn | CFO | 3,500 | $3.05 | $10.7K | 1 |
| 2022-05-12 | Buy | Nash Duane | Chair | 10,000 | $5.03 | $50.3K | 1 |
| 2022-05-12 | Buy | Muehler Andreas | Other C-suite | 3,500 | $5.10 | $17.8K | 1 |
| 2022-05-12 | Buy | Whaley Glenn | CFO | 3,000 | $5.08 | $15.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Neermann Joerg | Director | $204.7K | $0 | 2025-06-05 |
| Rudick Richard Alan | Director | $200.5K | $0 | 2025-06-03 |
| Whaley Glenn | CFO | $74.1K | $0 | 2025-06-03 |
| Nash Duane | Chair | $66.9K | $0 | 2025-06-13 |
| Vitt Daniel | CEO | $56.2K | $0 | 2025-06-04 |
| Muehler Andreas | Other C-suite | $17.8K | $0 | 2022-05-12 |
| Tardio Jason | President | $9.9K | $0 | 2025-06-05 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-06-03 → 2025-06-13 | 6 | $246.8K | 62 | -0.3% (+5.8% raw) | -4.4% (+8.5% raw) | -32.0% (-12.8% raw) | closed |
| 2022-11-07 → 2022-12-14 | 3 | $146.3K | 46 | -1.7% (-8.6% raw) | +39.6% (+42.4% raw) | +23.5% (+18.7% raw) | closed |
| 2022-05-12 → 2022-06-03 | 4 | $109.6K | 53 | -39.3% (-42.2% raw) | -27.0% (-13.4% raw) | -81.3% (-74.8% raw) | closed |
| 2021-08-10 | 3 | $34.2K | 47 | -4.9% (-5.5% raw) | -7.3% (+1.2% raw) | +49.7% (+42.9% raw) | closed |
| 2017-09-08 → 2017-09-14 | 3 | $985.5K | 31 | – | – | – | closed |
| 2017-06-06 → 2017-06-14 | 6 | $323.9K | 40 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.